# FDA Inspection 648367 - Martin Ekwealor Pharmaceuticals, Inc. - February 17, 2010

Source: https://www.globalkeysolutions.net/records/fda_inspections/martin-ekwealor-pharmaceuticals-inc/a660f0a3-01dd-421d-89d3-39014f6d005c
Source feed: FDA_Inspections

> FDA Inspection 648367 for Martin Ekwealor Pharmaceuticals, Inc. on February 17, 2010. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 648367
- Company Name: Martin Ekwealor Pharmaceuticals, Inc.
- Inspection Date: 2010-02-17
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1037070 - 2017-12-13](https://www.globalkeysolutions.net/records/fda_inspections/martin-ekwealor-pharmaceuticals-inc/dec31aec-257f-4e16-9e03-602b3541de53)
- [FDA Inspection 963197 - 2016-03-24](https://www.globalkeysolutions.net/records/fda_inspections/martin-ekwealor-pharmaceuticals-inc/a77b72c9-8fa9-4454-92b4-bf39588803ab)
- [FDA Inspection 741026 - 2011-07-29](https://www.globalkeysolutions.net/records/fda_inspections/martin-ekwealor-pharmaceuticals-inc/55bc5963-f909-4fad-81fb-50530d7015ef)

Company: https://www.globalkeysolutions.net/companies/martin-ekwealor-pharmaceuticals-inc/df2d727e-9b86-4711-b3e7-0b381ab35fe9

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c